UnitedHealth's Optum Rx PBM to coax patients into cheaper biosimilars of Abbvie's Humira

UnitedHealth’s Optum Rx PBM to coax patients into cheaper biosimilars of Abbvie’s Humira

AbbVie’s flagship drug, Humira, is shown in this illustration Friday, July 18, 2014 in Houston. … [+] On Tuesday, Nov. 15, 2022, UnitedHealth Group’s head of pharmaceutical benefits, OptumRx, said it would put three “biosimilar” versions of Abbvie’s expensive rheumatoid arthritis drug Humira “in the same position as the brand” on the PBM’s preferred medication …

UnitedHealth’s Optum Rx PBM to coax patients into cheaper biosimilars of Abbvie’s Humira Read More »